We read the editorial by Tujula et al. with great interest (1). They described the role of procalcitonin as biomarker for the diagnosis of infection and monitoring of antibiotic treatment. Despite… Click to show full abstract
We read the editorial by Tujula et al. with great interest (1). They described the role of procalcitonin as biomarker for the diagnosis of infection and monitoring of antibiotic treatment. Despite their meticulous citation data collection, several important issues need further consideration.In their report, the authors have claimed that 'proclacitonin seems to be a useful biomarker for severe bacterial infections and this is likely to be the case also in Obstetrics and Gynecology'. This article is protected by copyright. All rights reserved.
               
Click one of the above tabs to view related content.